Geeta Nayyar
Geeta Nayyar, MD, MBA, is a globally recognized chief medical officer, technologist, and bestselling author who helps leaders leverage a human approach to innovation, including rapid advances in AI, to achieve better health and business outcomes.
A widely sought-after speaker and author of the Wall Street Journal and USA Today bestseller Dead Wrong: Diagnosing and Treating Healthcare’s Misinformation Illness, Nayyar has appeared on prominent media outlets such as CNBC, CNN, Fox and ABC News. She has served as chief medical officer for Salesforce and AT&T, among other executive roles. She currently serves on the board of the American Telemedicine Association and as an advisor to the American Medical Association.
A rheumatologist, Nayyar earned her medical degree at the University of Miami Miller School of Medicine, where she was admitted into an accelerated program at age 17, and her MBA at the George Washington University School of Business.
John Fernandez
John Fernandez is president and CEO of Brown University Health, Rhode Island’s largest not-for-profit, academic health system affiliated with The Warren Alpert Medical School of Brown University. More than 550,000 people annually receive care at its hospitals and practices, including Rhode Island, Hasbro Children’s, The Miriam, Bradley, Newport, Saint Anne’s, and Morton hospitals, as well as Gateway Healthcare and Brown Health Medical Group.
Previously, Fernandez served as president of Mass Eye and Ear and Mass General Brigham Integrated Care, leading strategic initiatives to expand ambulatory services across New England. From 2007 to 2018, he was president and CEO of Mass Eye and Ear when it operated independently. Earlier in his career, he was vice president at Brigham and Women’s Hospital.
Fernandez has a strong record in expanding care, research, and training. He holds a bachelor’s in political science from The College of Wooster and a master’s from the University of Pennsylvania.
Kun-Hsing “Kun” Yu
Kun-Hsing “Kun” Yu, M.D, Ph.D. is an assistant professor in the Department of Biomedical Informatics at Harvard Medical School.
He developed the first fully automated AI algorithm to extract thousands of features from whole-slide histopathology images, discovered the molecular mechanisms underpinning the microscopic phenotypes of tumor cells, and successfully identified previously unknown cellular morphologies associated with patient prognosis.
His lab integrates cancer patients’ multi-omics (genomics, epigenomics, transcriptomics, and proteomics) profiles with quantitative histopathology patterns to predict their clinical phenotypes. More than 30 research laboratories worldwide have independently validated the AI methods developed in the Yu Lab.
Michael Arevalo
Michael Arevalo, Psy.D., is a licensed clinical psychologist with experience in evidence-based treatment and quality improvement across diverse clinical settings, including community mental health organizations, private practice, university counseling centers, and major healthcare systems like the VA and Kaiser Permanente.
As director of clinical strategy at Core Solutions, Inc., he leads the integration of clinical best practices into the company’s EHR platform, collaborating with product, engineering, and AI teams to develop data-driven solutions that enhance clinician workflows and patient care.
Arevalo also defines quality metrics, ensures regulatory compliance, and develops training programs to optimize digital health tools.
Akash Parvatikar
Akash Parvatikar received his Ph.D. in computational biology from the joint Carnegie-Mellon and University of Pittsburgh School of Medicine.
He specializes in biomedical imaging informatics and computational and systems pathology. Parvatikar investigates the intrinsic characteristics of biomedical images at multi-scale resolutions using statistical modeling, computer vision, machine learning, and graph-based deep learning techniques.
At HistoWiz, Parvatikar develops tools to ensure quality images, accelerates histopathology, and develops AI tools for preclinical researchers across academic, biotech, and pharmaceutical domains.
Allen Chang
Allen Chang is a physician and clinical informaticist with a passion for the transformative potential of AI in healthcare. After earning an undergraduate degree in electrical engineering from Brown University, he received his medical degree from UMass Chan Medical School and completed his internal medicine internship and residency at Massachusetts General Hospital.
For a decade, Dr. Chang practiced as a primary care internist while holding leadership roles in undergraduate and graduate medical education, as well as in care transformation and clinician wellness. It was through his work in addressing clinician burnout that he became deeply interested in AI’s potential to enhance healthcare delivery and efficiency.
This interest led Dr. Chang to join the inaugural class of UMass Chan’s Clinical Informatics fellowship, where he has been a key leader driving UMass Memorial Health’s AI governance and policy, vendor assessment, and implementation. With a particular passion for AI literacy and competency in healthcare, he continues to practice clinically while helping shape AI adoption strategies in complex healthcare environments.
Upon completing the fellowship, Dr. Chang will serve as the Associate Chief of Clinical Informatics for AI at UMass Memorial Health, continuing to lead efforts to integrate AI responsibly and effectively into patient care.
Leslie D. Parker
Leslie D. Parker, Esq. specializes in health care law and commercial litigation.
In her healthcare practice, Leslie employs her deep understanding of the industry and regulatory environment to counsel a wide variety of health care industry clients in matters before state and federal regulatory agencies. She has extensive experience guiding clients through complex regulatory processes, including Change in Effective Control and Certificate of Need proceedings and throughout Hospital Conversions Act reviews.
Parker also routinely represents clients in Medicare appeals, as well as throughout the Medicare and Medicaid provider enrollment process. She employs her extensive knowledge of the health care industry when representing providers and other entities in business disputes and before state and federal regulatory agencies involving issues of professional liability and licensing.
Aidan Petrie
Aidan Petrie is a founding Partner of NEMIC (New England Medical Innovation Center), New England’s MedTech venture hub and a Fellow of the Provost at RISD, focused on intersections between user-centered design and healthcare. He is a member of Cherrystone Angels and a mentor and advisor to many startups.
He also co-founded the Magpie MedTech Venture Fund, which provides pre-seed capital investment and clinical and regulatory expertise to Medical Technology and Digital Health startups through a synergistic partnership with NEMIC. Petrie was the founding partner of Ximedica (now part of Veranex), one of the world’s leading medical device developers.
Petrie’s passion for innovation and design has helped bring hundreds of products to market, ranging from simple drug compliance aids to wearable therapeutics, home monitoring products, and complex surgical systems.
Daniel Colling
Daniel Colling is HP Inc.’s Global Head for Healthcare Industry Solutions & Practice, leading HP’s healthcare strategy, technology, and services to support improved patient safety, clinical efficiency, care coordination, and business value through connected care. His outcomes-based, evidence-driven approach helps global health systems implement value-based care, population health management, and precision medicine using HP’s tailored solutions.
With over 20 years of experience, Colling has held clinical executive and IT roles in U.S. and Canadian health systems, focusing on patient safety, clinical workflows, telehealth, interoperability, 3D printing, VR, AI, and digital transformation. He has supported organizations in achieving EMRAM Stage 7 and best practices in clinical decision support.
A recognized speaker and public policy advocate, Colling holds BSc degrees in Nursing and Information Systems & Architecture from the University of British Columbia and a Master of Applied Science in Population Health Management from Johns Hopkins. He serves on the board of the Global Access to Cancer Care Foundation.
Naveed Afzal
Naveed Afzal is a recognized expert in Natural Language Processing with a Ph.D. from the University of Wolverhampton and a master’s in advanced software engineering from the University of Sheffield. He has authored a book and over 45 academic publications.
As Head of Data Science at Takeda, a leading biopharmaceutical company, Dr. Afzal leads a global team, drives data science and AI initiatives, collaborates with business units, shapes data strategies, streamlines workflows, and promotes innovation. His career spans academia, research, and the healthcare industry, with a focus on Data, AI, Responsible AI, and Cybersecurity. He actively shares his expertise through blog articles on Medium and engages in thought leadership.
Dr. Afzal’s work reflects a deep commitment to advancing ethical and impactful AI in healthcare.
Gregor Mittersinker
Gregor Mittersinker, Austrian-born CEO and founder of LOFT Design, leads a globally recognized product development firm known for integrating UX, Engineering, and Data Science to create innovative ecosystems in Life Sciences and MedTech.
With over 30 years of experience, he’s launched 500+ products, holds 100+ patents, and is distinguished by numerous honors including the Fast Company Innovation by Design Award, IDSA IDEA Awards, Good Design Awards, Red Dot Design Awards, and Core77 Design Awards.
Mittersinker has worked with brands like Thermo Fisher, 3M, and 908 Devices across Europe, the U.S., and Asia. He holds degrees from the Technical University and University of Applied Arts Vienna and teaches UX at RISD.
Severence M. MacLaughlin
Severence M. MacLaughlin, Ph.D., is a globally recognized AI scientist and the Founder and CEO of Delorean AI.
Ranked the No. 2 Data Scientist in the World for Healthcare, he has led transformative AI initiatives across the healthcare sector. MacLaughlin previously served as Chief of Intelligence for the Western Hemisphere at Capgemini Invent and as Global Head of AI for Healthcare & Life Sciences at Cognizant.
A trusted advisor, he consults with international governments, the United, and World Health Organization. Known for advancing strategic intelligence and innovation, MacLaughlin continues to shape global AI policy and applications in health and life sciences.